BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 27
• 28
• 29

• Pharm Country

  Mylan Inc. Committed to Expanding Access in Developing Countries to High Quality, Affordable HIV/AIDS Treatment

  December 1, 2011

   · 

  3 min read
• Drug Development

  Ceregene, Inc. Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinson’s Disease

  December 1, 2011

   · 

  6 min read
• Pharm Country

  Mylan Inc. Launches Generic Version of Caduet(R) Tablets

  December 1, 2011

   · 

  1 min read
• Policy

  Genetic Technologies Limited Executes Settlement and License Agreement with AutoImmun Diagnostika GmbH

  December 1, 2011

   · 

  3 min read
• Pharm Country

  Immune Response BioPharma Corporate Update 2011 Investor Presentation Available Online

  December 1, 2011

   · 

  1 min read
• Pharm Country

  Merck & Co., Inc. Release: HIV Clinic Experts Convene to Launch First-of-its-Kind HIV Clinic Resource Initiative

  December 1, 2011

   · 

  5 min read
• Biotech Bay

  BioMarin Pharmaceutical Inc. Announces Buy Back of Naglazyme Royalties From Adelaide Health Authority

  December 1, 2011

   · 

  4 min read
• BioMidwest

  Cardinal Health, Inc. Unveils New Unit-dose, Barcoded Packaging Solutions for Oral Liquid Medications

  December 1, 2011

   · 

  3 min read
• Genetown

  Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin

  December 1, 2011

   · 

  3 min read
• Policy

  PRC Increases Goals of Healthcare Reform

  December 1, 2011

   · 

  1 min read